1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Rachel Jones: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rituximab and Belimumab Combination Therapy in PR3 Vasculitis Belimumab, Rituximab, Prednisolone - ANCA Associated Vasculitis, Granulomatosis With Polyangiitis | Phase 2 | Unknown | Rachel Jones | 31 | 2019-02-01 | 2022-03-08 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Granulomatosis with Polyangiitis (1)
Prednisolone (1) · Prednisone (1) · Rituximab (1) · belimumab (1)
United Kingdom (1)
Rachel B Jones (1)